Three Pharma Titans All Hike the Price of at Least One Brand-Name Drug This Year
Pharma titans Pfizer, Merck, and Bristol-Myers all hiked the price of at least one brand-name drug this year—with Pfizer doing so for a whopping 133 drugs. Critics complain that the resulting revenue boost simply hides sliding sales, downplays a lack of company innovation, and is sure to trigger a public policy backlash.